ioversol has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, XP | 1 |
| Ni, JM | 1 |
| Zhang, ZY | 1 |
| Lu, FQ | 1 |
| Li, B | 1 |
| Jin, HH | 1 |
| Dai, T | 1 |
| Beddar, AS | 1 |
| Briere, TM | 1 |
| Balter, P | 1 |
| Pan, T | 1 |
| Tolani, N | 1 |
| Ng, C | 1 |
| Szklaruk, J | 1 |
| Krishnan, S | 1 |
2 other studies available for ioversol and Bile Duct Cancer
| Article | Year |
|---|---|
Preoperative Evaluation of Malignant Perihilar Biliary Obstruction: Negative-Contrast CT Cholangiopancreatography and CT Angiography Versus MRCP and MR Angiography.
Topics: Adult; Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Cholangiopancreatography, Magnetic Resonance; | 2015 |
4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contra | 2008 |